2025-02-15
31Today, the "2026 China Pharmaceutical Industry Technology Conference & the 16th Annual Conference of the China Pharmaceutical Equipment Engineering Association," hosted by the China Pharmaceutical Equipment Engineering Association, concluded successfully at the Shangri-La Hotel, Suzhou! With the theme "Embracing Diversity, Innovating for Win-Win," the conference brought together authoritative industry experts and hundreds of representatives from pharmaceutical enterprises, suppliers, and research institutes across the country to discuss high-quality development of the pharmaceutical industry and the construction of new quality productive forces.
Jiangsu JV Bio-Equipment Co., Ltd. (hereinafter referred to as "JV Bio") was invited by the China Pharmaceutical Equipment Engineering Association to co-organize the Biopharmaceutical Technology Forum. During the conference, JV Bio presented its one-stop solutions, engaging in discussions with industry experts and pharmaceutical company representatives on pathways for biologics process upgrading and industrialization development.
During the conference, JV Bio comprehensively showcased its core technologies and equipment capabilities covering niche areas such as antibody drugs, vaccines, collagen, sodium hyaluronate, and peptide drugs. From process development and equipment manufacturing to engineering implementation, JV Bio is driven by technological innovation, providing biopharmaceutical enterprises with end-to-end one-stop solutions covering the full lifecycle.
The booth attracted numerous attendees who stopped by for in-depth exchanges. The technical team engaged in thorough discussions with visitors on practical topics such as process optimization, quality control, and scale-up production.
During the conference, You Jiali, Technical Director of Jiangsu JV Bio-Equipment Co., Ltd., delivered a presentation titled "Integrating the 'Quality by Design' Concept into Biopharmaceutical Tank and Piping Systems," sharing cutting-edge practices and systematic solutions. Targeting common industry pain points such as low CIP cleaning efficiency and difficult microbial control, the core of her proposed approach is: define critical process parameters through precise engineering calculations, and continuously optimize sanitary design, dead-leg control, and fluid dynamics performance based on risk assessment—thereby building a robust and efficient production system within the design space, ultimately achieving an organic unity of product quality and production efficiency.
This approach of systematically solving quality control issues from the design source provides a clear and actionable direction for the industry. The on-site exchange atmosphere was lively, with engaging speeches and interactive sessions that effectively stimulated in-depth thinking among attendees on the evolution of biologics process technology and future industry development.
Under the theme "Embracing Diversity, Innovating for Win-Win," this conference brought together nearly 100 authoritative experts and over 1,000 industry representatives. Leveraging this platform, JV Bio engaged in extensive exchanges with upstream and downstream enterprises and research institutes across the industry chain, gaining deeper insights into industry needs and development trends, and accumulating valuable experience for future technological iteration and service optimization.
Looking ahead, JV Bio will continue to deepen its presence in the high-end biopharmaceutical equipment sector, empowering industrial upgrading through technological innovation, and working alongside industry partners to drive the high-quality development of biologics.
